Placebo + Nicotine
Phase 3Terminated 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Mar 1, 2011 → Jun 1, 2011
NCT ID
NCT01296698About Placebo + Nicotine
Placebo + Nicotine is a phase 3 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is terminated. This product is registered under clinical trial identifier NCT01296698. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01296698 | Phase 3 | Terminated |
Competing Products
20 competing products in Tobacco Dependence